You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JAZZ Exercise Disclosure
Iannone Robert · SEC Form 4 · Filed Aug 31, 2026
Exercise
Calculated transaction value
$0
Iannone Robert EVP, Global Head Of R&d & CMO
JAZZ
Jazz Pharmaceuticals
JAZZ
Transaction date
Aug 27, 2026
Public filing date
Aug 31, 2026
Filing lag
Filed 4 days later
JAZZ daily price context
Close on/before transaction
$251.1
Aug 27, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right to buy) on Ordinary Shares
- Quantity / price
- 26,116 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001737329-26-000016
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$26.44M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Aug 27, 2026 | $2.95M |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Aug 27, 2026 | $99.98K |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Aug 27, 2026 | $3.78M |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Aug 27, 2026 | $399.84K |
| Jazz Pharmaceuticals Plc JAZZ | Sale | Aug 27, 2026 | $4.51M |
| Jazz Pharmaceuticals Plc JAZZ | Sale | Aug 27, 2026 | $2.84M |
| Jazz Pharmaceuticals Plc JAZZ | Sale | Aug 27, 2026 | $4.53M |
| Jazz Pharmaceuticals Plc JAZZ | Sale | Aug 27, 2026 | $4.92M |
| Jazz Pharmaceuticals Plc JAZZ | Sale | Aug 27, 2026 | $2.33M |
| Jazz Pharmaceuticals Plc JAZZ | Sale | Aug 27, 2026 | $75.83K |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Aug 27, 2026 | $0 |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Aug 27, 2026 | $0 |
| Jazz Pharmaceuticals Plc JAZZ Current | Exercise | Aug 27, 2026 | $0 |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Aug 27, 2026 | $0 |